Rafael Yáñez, CEO and founder of GeneticAI: thanks CDTI Innovation we are developing a solution that improves the well-being of patients with psychiatric illnesses ”

In a world where technology is advancing at a dizzying pace, GeneticAI is positioned as a reference in different disruptive technologies with the aim of improving people's lives. This company was founded in 2018 and with headquarters in Madrid, combines technological innovation with a strong social commitment, developing solutions whose aim is to promote active ageing, the personalization of healthcare and the improvement of physical and mental health.

“ GeneticAI born as an initiative to transform traditional sectors through disruptive technologies as artificial intelligence augmented reality and the internet of things. Our aim is clear: implement innovation to improve the lives of persons, ” explains Rafael Yáñez, CEO and founder of the company.

GeneticAI team

Towards a cognitive monitoring more humane and accessible

Today, there are many tools to monitor the cognitive activity in people with neurological diseases such as stroke or párkinson. However, many of these solutions are based on repetitive or tests in the use of sensors and invasive uncomfortable that often have complex interpretations and difficult to access by the patient himself or his environment.

Against this traditional approach, the new draft GeneticAI proposes an approach focused on the person through the development of AI4COCOMO a technological platform of personalized neurorrehabilitación combining vestibles sensors, models of artificial intelligence that they learn of the data, known as machine learning, and advanced natural language processing, called LLMs, adapted to the context of the patient.

“ the idea of this project arises from the social challenge posed by the stroke and párkinson, in addition to the lack of tools that allow continued follow-up, and non-intrusive. The aim is to improve the quality of patient's life, early detection of cognitive impairment and offer treatment adapted in real time based on evidence, ” explains Yáñez.

One of the great challenges in the follow-up of patients with cognitive impairment is how to collect useful data without invade their privacy or to alter their daily routine. Therefore, the company is committed to the use of intelligent templates and bracelets easily activity integrables in everyday life of the user. “ These devices collected valuable information on physical activity and forwarded, through a mobile application which serves as the interface and gateway to the cloud. There, the algorithms of artificial intelligence analyse the data and extract patterns that help customize medical monitoring ”, underlines the CEO.

Evidence of the solution in the association Párkinson Madrid

Solution designed with and for persons

Another key aspect of the project is its participatory approach, based on collaboration among various professional profiles and users. In the design and development of active AI4COCOMO neurologists, speech therapists, carers and patients, whose views and needs are taken into account at an early stage.

“ one of the salient features of this initiative is precisely this cooperation. We Have opted for a model of co-diseño involving clinical specialists, carers and, of course, the patients themselves. His life experiences and expectations guided the entire process of development, ” says Yáñez.

This solution has been designed with a modular approach, which lets you customize the interface like the kind of interaction and the level of complexity. “ All this makes it possible to adapt the solutions to common user profiles, from older people with mild cognitive impairment to health professionals who need a more detailed overview, ” she adds.

This project aims to significantly improve GeneticAI the quality of life of patients to facilitate their autonomy and, furthermore, contribute to relieving the health system by providing accessible and flexible tools for the follow-up remote.

Momentum towards innovation

The path of GeneticAI towards technological innovation in health has been supported by the CDTI program. This helps Neotec, aimed at supporting startups with a strong technological base, has been key to the company to develop pioneering solutions in artificial intelligence applied to the well-being. “ for us the support of CDTI has been key to accelerating the technical and scientific validation of the project — ensures Yáñez. In addition, the support of Neotec has enabled us to make significant progress towards solutions immersive applications in health and helped us to settle the technological basis of the company that today as feed AI4COCOMO projects ”.

CDTI Innovation

The centre for technological development and innovation, CDTI E.P.E. is a public company under the ministry of Science, innovation and universities, whose goal is the promotion of technological innovation in business. The CDTI mission is to ensure that the business fabric english generates and transform knowledge into growth científico-técnico globally competitive, sustainable and inclusive. By 2024, within the framework of a new strategic plan, the CDTI provided more than $2.3 billion euros of support for business startups and spain.

More information:

Office of the press
prensa@cdti.es
91-581.55.00

On The Internet
Website:www.cdti.es
In Linkedin:https :// www.linkedin.com/company/29815
X:https :// twitter.com/CDTI _ innovation
On Youtube:https :// www.youtube.com/user/CDTIoficial

GeneticAI

Website:https :// genetic.ai
Site of the project funded by Neotec:https :// www.gwydion.space

This content is copyright © 2025 CDTI, Soes. Permitted for use and reproduction by quoting the source and digital identity of CDTI (@CDTI _ innovation).